Novartis | NVS - Eigenkapital Und Reserven

Aktienkurs
144.23
Täglich Wechseln
-0.02 -0.01%
Monatlich
-4.09%
Jährlich
27.14%
Q2 Prognose
142.62




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bausch Health Companies USD -554M 910M 2025-12
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
J&J USD 81.19B 358M 2026-03
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Sanofi EUR 71.71B 14.25B 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Zoetis USD 3.33B 2.07B 2025-12